TY  - GEN
AU  - Rincon, Esther
AU  - Cejalvo, Teresa
AU  - Kanojia, Deepak
AU  - Alfranca, Arantzazu
AU  - Rodriguez-Milla, Miguel A
AU  - Gil Hoyos, Raul Andrés
AU  - Han, Yu
AU  - Zhang, Lingjiao
AU  - Alemany, Ramón
AU  - Lesniak, Maciej S
AU  - Garcia-Castro, Javier
PY  - 2017
DO  - 10.18632/oncotarget.17557
SN  - 1949-2553
UR  - http://hdl.handle.net/20.500.12105/9612
AB  - Oncolytic virotherapy represents a promising alternative for cancer treatment; however, viral delivery to the tumor represents a major challenge. Mesenchymal stem cells (MSCs) chemotax to tumors, and can serve as a viral delivery tool. Previously, we...
LA  - eng
PB  - Impact Journals
KW  - Cancer
KW  - Carriers
KW  - Immunotherapy
KW  - Mesenchymal stem cells
KW  - Oncolytic adenoviruses
KW  - Animals
KW  - Cell Line, Tumor
KW  - Cell Movement
KW  - Cell Survival
KW  - Cytokines
KW  - Disease Models, Animal
KW  - Gene Expression
KW  - Genes, Reporter
KW  - Genetic Therapy
KW  - Humans
KW  - Immunotherapy
KW  - Inflammation Mediators
KW  - Lymphocytes, Tumor-Infiltrating
KW  - Mesenchymal Stem Cells
KW  - Mice
KW  - Transduction, Genetic
KW  - Xenograft Model Antitumor Assays
KW  - Adenoviridae
KW  - Genetic Vectors
KW  - Mesenchymal Stem Cell Transplantation
KW  - Oncolytic Virotherapy
KW  - Oncolytic Viruses
TI  - Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model
TY  - research article
ER  -